
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Sir Alastair Currie Cancer Research UK Laboratories, Molecular Medicine Centre, The University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom;
2 University of Cambridge Pathology Department, Addenbrooke's Hospital, Cambridge, United Kingdom;
3 Comparative and Developmental Genetics Section, MRC Human Genetics Unit, Western General Hospital, Edinburgh, United Kingdom; and
4 Division of Reproductive and Developmental Sciences, Genes and Development Group, University of Edinburgh, Hugh Robson Building, Edinburgh, United Kingdom
Requests for reprints: Roberta M. James, Sir Alastair Currie Cancer Research UK Laboratories, Molecular Medicine Centre, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, United Kingdom. Phone: 44-131-651-1080; Fax: 44-131-651-1072. E-mail: roberta.james{at}ed.ac.uk
Ras proteins transduce signals from membrane-bound receptors via multiple downstream effector pathways and thereby affect fundamental cellular processes, including proliferation, apoptosis, and differentiation. K-ras activating mutations play a key role in neoplastic progression and are particularly prevalent in colorectal, pancreatic, and lung cancers. The present study addressed whether the K-ras proto-oncogene displays a tumor suppressor function by comparative analysis of mouse teratomas derived from wild-type embryonic stem (ES) cells, K-ras null (K-ras-/-) ES cells, and K-ras-/- ES cells that stably reexpress either wild-type K-rasgly12 or oncogenic K-rasval12. K-ras-/- and K-rasval12 teratomas were significantly larger than teratomas that expressed wild-type K-ras, contained significantly higher proportions of undifferentiated embryonal carcinoma-like cells, and showed significantly increased mitotic activity. However, K-rasval12 but not K-ras-/- teratomas exhibited significantly higher levels of apoptosis than wild-type teratomas. K-ras-/- and K-rasval12 ES cells showed a higher capacity for stem cell self-renewal in vitro compared with wild-type ES cells, and reexpression of K-rasgly12 in K-ras-/- ES cells restored the K-ras-/- phenotype to wild-type values. Thus, in view of evidence that tumors can derive from tissue stem cells and that tumors harbor "cancer stem cells," aberrant K-ras expression could promote neoplastic progression by increasing their capacity for self-renewal.
Key Words: K-ras tumor suppressor stem cell self-renewal teratoma
This article has been cited by other articles:
![]() |
F. Dayyani, J. Wang, J.-R. J. Yeh, E.-Y. Ahn, E. Tobey, D.-E. Zhang, I. D. Bernstein, R. T. Peterson, and D. A. Sweetser Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival Blood, April 15, 2008; 111(8): 4338 - 4347. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Binetruy, L. Heasley, F. Bost, L. Caron, and M. Aouadi Concise Review: Regulation of Embryonic Stem Cell Lineage Commitment by Mitogen-Activated Protein Kinases Stem Cells, May 1, 2007; 25(5): 1090 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hao, X. Li, T. Qiao, J. Zhang, X. Shao, and D. Fan Distribution of CIAPIN1 in Normal Fetal and Adult Human Tissues J. Histochem. Cytochem., April 1, 2006; 54(4): 417 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-R. Yuan, R. Wang, J. Solomon, X. Luo, H. Sun, L. Zhang, and Y. Shi Identification and Characterization of Survival-Related Gene, a Novel Cell Survival Gene Controlling Apoptosis and Tumorigenesis Cancer Res., December 1, 2005; 65(23): 10716 - 10724. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Diaz, L. Lopez-Barcons, D. Ahn, A. Garcia-Espana, A. Yoon, J. Matthews, R. Mangues, R. Perez-Soler, and A. Pellicer Complex effects of Ras proto-oncogenes in tumorigenesis Carcinogenesis, April 1, 2004; 25(4): 535 - 539. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |